Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Nine Oxford academics have received European Research Council (ERC) Advanced Grants to fund cutting-edge research projects that address some of today’s most pressing challenges.

None © Shutterstock

The awards, funded through the EU and worth up to €2.5 million each, allow established top researchers from across disciplines to explore their most creative ideas. The grants will also lead to the creation of jobs including postdoctoral and doctoral research positions.

Projects led by Oxford include one that will make synthetic tissues for applications in medicine, and another probing the information flows between companies and consumers, filling a gap in economic understanding and policy.

The Oxford researchers receiving awards in the latest round of funding are:

  • Professor Mark Armstrong, Department of Economics          
  • Professor Hagan Bayley, Department of Chemistry
  • Professor Benjamin Berks, Department of Biochemistry
  • Professor Veronique Gouverneur, Department of Chemistry        
  • Professor Marta Kwiatkowska, Department of Computer Science
  • Professor Gero Miesenboeck, Department of Physiology, Anatomy and Genetics
  • Professor Melinda Mills, Department of Sociology
  • Professor Judith Rousseau, Department of Statistics
  • Professor Stuart West, Department of Zoology

Read more (Department of Physiology, Anatomy and Genetics website)

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.